BG
Last reporting period 30 Sep, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
0.008
Exchange
XNAS - Nasdaq
—
Last period Earnings quality
What is Earnings quality ?
Earnings quality is the ability to confirm the profit accrued in the financial statements by actually received cash on the company accounts. The value of 100% is the benchmark for Eyestock Rating calculation.
See also BioNexus Gene
Company Analysis
BGLC valuation, rating, competitors, insights and company profile
Eyestock Rating
BGLC financial analysis by Eyestock methodology
Valuation
BGLC valuation using historical relative method
Statements
BGLC Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BGLC dividend yield and annual dividend
Earnings quality is the ability to confirm the profit accrued in the financial statements by actually received cash on the company accounts. The value of 100% is the benchmark for Eyestock Rating calculation.
BioNexus Gene`s Earnings quality for the last twelve months ended 2023-09-30 is —
